Ibrutinib + Venetoclax Promising for Chronic Lymphocytic Leukemia
WEDNESDAY, June 23, 2021 -- Combination therapy with ibrutinib and venetoclax seems beneficial for patients with previously untreated chronic lymphocytic leukemia (CLL), according to a study published online June 10 in JAMA Oncology.
Nitin Jain,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Pharmaceuticals | Study